US Stock MarketDetailed Quotes

SRPT Sarepta Therapeutics

Watchlist
  • 128.770
  • +1.380+1.08%
Close Apr 26 16:00 ET
  • 128.770
  • 0.0000.00%
Post 17:05 ET
12.17BMarket Cap-22201P/E (TTM)

Sarepta Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-53.99%-500.99M
40.84%-54.66M
-76.57%-114.71M
-82.94%-122.23M
-106.96%-209.4M
26.59%-325.35M
-215.05%-92.39M
47.75%-64.96M
38.78%-66.82M
43.91%-101.18M
Net income from continuing operations
23.81%-535.98M
141.79%45.66M
84.12%-40.94M
89.66%-23.94M
-392.03%-516.76M
-67.99%-703.49M
10.44%-109.24M
-435.35%-257.74M
-184.36%-231.48M
37.20%-105.03M
Operating gains losses
190.81%401.82M
8.61%3.86M
-97.17%3.5M
-45.84%3.92M
10,585.28%390.55M
1,120.10%138.18M
364.44%3.55M
2,849.68%123.74M
74.40%7.23M
64.64%3.66M
Depreciation and amortization
6.05%44.4M
7.76%11.37M
2.10%10.93M
9.13%10.79M
5.47%11.31M
10.12%41.86M
4.02%10.55M
1.98%10.7M
17.07%9.89M
20.03%10.72M
Other non cash items
-866.48%-96.81M
-103.48%-250K
227.46%3.23M
-16,753.52%-101.75M
-48.92%1.96M
113.45%12.63M
16.48%7.19M
119.35%987K
100.61%611K
-14.71%3.85M
Change In working capital
-1,118.87%-481.09M
-192.43%-150.29M
-1,649.29%-154.71M
-203.47%-47.03M
-196.56%-129.06M
59.79%-39.47M
-211.98%-51.39M
108.54%9.99M
50.65%45.45M
24.04%-43.52M
-Change in receivables
-201.27%-185.7M
-521.02%-81.47M
-3,598.81%-82.05M
49.45%-12.97M
63.47%-9.21M
-19.34%-61.64M
-309.58%-13.12M
110.53%2.35M
-175.41%-25.66M
-49.46%-25.2M
-Change in inventory
-190.89%-147.71M
-959.73%-94.1M
-0.29%-26.61M
-150.00%-26.69M
93.47%-306K
39.38%-50.78M
67.43%-8.88M
-34.61%-26.54M
62.44%-10.68M
44.02%-4.69M
-Change in payables and accrued expense
-133.97%-50.14M
374.36%61.09M
-133.00%-17.55M
-130.20%-26.13M
-1,244.90%-67.54M
533.44%147.57M
-81.55%12.88M
200.45%53.2M
68.31%86.52M
88.83%-5.02M
-Change in other current assets
-173.28%-10.71M
20.50%-15.72M
-272.68%-6M
134.08%41.01M
-323.83%-30M
-85.83%14.62M
-168.09%-19.78M
616.91%3.48M
-54.79%17.52M
-61.62%13.4M
-Change in other working capital
2.71%-86.83M
10.74%-20.08M
0.00%-22.5M
0.00%-22.25M
0.00%-22.01M
0.00%-89.24M
0.00%-22.49M
0.00%-22.5M
0.00%-22.25M
0.00%-22.01M
Cash from discontinued investing activities
Operating cash flow
-53.99%-500.99M
40.84%-54.66M
-76.57%-114.71M
-82.94%-122.23M
-106.96%-209.4M
26.59%-325.35M
-215.05%-92.39M
47.75%-64.96M
38.78%-66.82M
43.91%-101.18M
Investing cash flow
Cash flow from continuing investing activities
84.16%-165.8M
-756.98%-64.36M
-1,201.37%-210.57M
133.32%96.63M
101.59%12.49M
-311.32%-1.05B
480.13%9.8M
-5.66%19.12M
-190.32%-289.99M
-601.58%-785.81M
Net PPE purchase and sale
-146.91%-76.11M
-139.06%-19.04M
-260.50%-29.67M
-97.28%-17.91M
-70.87%-9.49M
19.92%-30.82M
-261.02%-7.96M
10.93%-8.23M
-54.02%-9.08M
73.75%-5.55M
Net intangibles purchase and sale
-687.60%-11.24M
--0
----
----
----
38.20%-1.43M
---202K
----
----
----
Net investment purchase and sale
82.21%-180.46M
-352.30%-45.32M
-709.53%-169.8M
104.48%12.59M
102.83%22.07M
-333.67%-1.01B
1,097.89%17.96M
-7.15%27.86M
-224.20%-280.68M
-533.18%-779.77M
Net other investing changes
--102M
--0
--139K
44,046.12%101.96M
80.66%-94K
----
----
----
-100.23%-232K
77.87%-486K
Cash from discontinued investing activities
Investing cash flow
84.16%-165.8M
-756.98%-64.36M
-1,201.37%-210.57M
133.32%96.63M
101.59%12.49M
-311.32%-1.05B
480.13%9.8M
-5.66%19.12M
-190.32%-289.99M
-601.58%-785.81M
Financing cash flow
Cash flow from continuing financing activities
-46.24%125M
-81.92%1.94M
-92.88%15.41M
1,628.91%5.86M
1,939.98%101.8M
-58.60%232.51M
-98.04%10.75M
3,567.05%216.43M
-90.39%339K
72.49%4.99M
Net issuance payments of debt
--0
--0
----
----
----
--304.17M
--0
----
----
----
Net common stock issuance
--0
----
----
----
----
--0
----
----
----
----
Proceeds from stock option exercised by employees
285.91%131.89M
-82.81%1.94M
117.59%15.41M
1,628.91%5.86M
2,078.00%108.68M
-441.05%-70.95M
426.21%11.3M
-1,583.85%-87.58M
-90.39%339K
-45.91%4.99M
Net other financing activities
-861.87%-6.89M
--0
--0
--0
---6.89M
90.78%-716K
61.31%-554K
----
----
----
Cash from discontinued financing activities
Financing cash flow
-46.24%125M
-81.92%1.94M
-92.88%15.41M
1,628.91%5.86M
1,939.98%101.8M
-58.60%232.51M
-98.04%10.75M
3,567.05%216.43M
-90.39%339K
72.49%4.99M
Net cash flow
Beginning cash position
-53.62%985.8M
-46.95%561.08M
-1.82%870.95M
-28.37%890.69M
-53.62%985.8M
40.60%2.13B
-34.23%1.06B
-48.01%887.06M
-16.59%1.24B
40.60%2.13B
Current changes in cash
52.46%-541.79M
-62.95%-117.07M
-281.65%-309.87M
94.46%-19.74M
89.22%-95.11M
-285.68%-1.14B
-113.89%-71.85M
273.78%170.58M
-265.46%-356.47M
-4,137.90%-881.99M
End cash Position
-54.96%444.01M
-54.96%444.01M
-46.95%561.08M
-1.82%870.95M
-28.37%890.69M
-53.62%985.8M
-53.62%985.8M
-34.23%1.06B
-48.01%887.06M
-16.59%1.24B
Free cash flow
-64.53%-588.34M
26.71%-73.7M
-109.11%-155.62M
-84.66%-140.14M
-105.09%-218.88M
26.11%-357.6M
-197.15%-100.56M
44.28%-74.42M
34.03%-75.89M
47.04%-106.73M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -53.99%-500.99M40.84%-54.66M-76.57%-114.71M-82.94%-122.23M-106.96%-209.4M26.59%-325.35M-215.05%-92.39M47.75%-64.96M38.78%-66.82M43.91%-101.18M
Net income from continuing operations 23.81%-535.98M141.79%45.66M84.12%-40.94M89.66%-23.94M-392.03%-516.76M-67.99%-703.49M10.44%-109.24M-435.35%-257.74M-184.36%-231.48M37.20%-105.03M
Operating gains losses 190.81%401.82M8.61%3.86M-97.17%3.5M-45.84%3.92M10,585.28%390.55M1,120.10%138.18M364.44%3.55M2,849.68%123.74M74.40%7.23M64.64%3.66M
Depreciation and amortization 6.05%44.4M7.76%11.37M2.10%10.93M9.13%10.79M5.47%11.31M10.12%41.86M4.02%10.55M1.98%10.7M17.07%9.89M20.03%10.72M
Other non cash items -866.48%-96.81M-103.48%-250K227.46%3.23M-16,753.52%-101.75M-48.92%1.96M113.45%12.63M16.48%7.19M119.35%987K100.61%611K-14.71%3.85M
Change In working capital -1,118.87%-481.09M-192.43%-150.29M-1,649.29%-154.71M-203.47%-47.03M-196.56%-129.06M59.79%-39.47M-211.98%-51.39M108.54%9.99M50.65%45.45M24.04%-43.52M
-Change in receivables -201.27%-185.7M-521.02%-81.47M-3,598.81%-82.05M49.45%-12.97M63.47%-9.21M-19.34%-61.64M-309.58%-13.12M110.53%2.35M-175.41%-25.66M-49.46%-25.2M
-Change in inventory -190.89%-147.71M-959.73%-94.1M-0.29%-26.61M-150.00%-26.69M93.47%-306K39.38%-50.78M67.43%-8.88M-34.61%-26.54M62.44%-10.68M44.02%-4.69M
-Change in payables and accrued expense -133.97%-50.14M374.36%61.09M-133.00%-17.55M-130.20%-26.13M-1,244.90%-67.54M533.44%147.57M-81.55%12.88M200.45%53.2M68.31%86.52M88.83%-5.02M
-Change in other current assets -173.28%-10.71M20.50%-15.72M-272.68%-6M134.08%41.01M-323.83%-30M-85.83%14.62M-168.09%-19.78M616.91%3.48M-54.79%17.52M-61.62%13.4M
-Change in other working capital 2.71%-86.83M10.74%-20.08M0.00%-22.5M0.00%-22.25M0.00%-22.01M0.00%-89.24M0.00%-22.49M0.00%-22.5M0.00%-22.25M0.00%-22.01M
Cash from discontinued investing activities
Operating cash flow -53.99%-500.99M40.84%-54.66M-76.57%-114.71M-82.94%-122.23M-106.96%-209.4M26.59%-325.35M-215.05%-92.39M47.75%-64.96M38.78%-66.82M43.91%-101.18M
Investing cash flow
Cash flow from continuing investing activities 84.16%-165.8M-756.98%-64.36M-1,201.37%-210.57M133.32%96.63M101.59%12.49M-311.32%-1.05B480.13%9.8M-5.66%19.12M-190.32%-289.99M-601.58%-785.81M
Net PPE purchase and sale -146.91%-76.11M-139.06%-19.04M-260.50%-29.67M-97.28%-17.91M-70.87%-9.49M19.92%-30.82M-261.02%-7.96M10.93%-8.23M-54.02%-9.08M73.75%-5.55M
Net intangibles purchase and sale -687.60%-11.24M--0------------38.20%-1.43M---202K------------
Net investment purchase and sale 82.21%-180.46M-352.30%-45.32M-709.53%-169.8M104.48%12.59M102.83%22.07M-333.67%-1.01B1,097.89%17.96M-7.15%27.86M-224.20%-280.68M-533.18%-779.77M
Net other investing changes --102M--0--139K44,046.12%101.96M80.66%-94K-------------100.23%-232K77.87%-486K
Cash from discontinued investing activities
Investing cash flow 84.16%-165.8M-756.98%-64.36M-1,201.37%-210.57M133.32%96.63M101.59%12.49M-311.32%-1.05B480.13%9.8M-5.66%19.12M-190.32%-289.99M-601.58%-785.81M
Financing cash flow
Cash flow from continuing financing activities -46.24%125M-81.92%1.94M-92.88%15.41M1,628.91%5.86M1,939.98%101.8M-58.60%232.51M-98.04%10.75M3,567.05%216.43M-90.39%339K72.49%4.99M
Net issuance payments of debt --0--0--------------304.17M--0------------
Net common stock issuance --0------------------0----------------
Proceeds from stock option exercised by employees 285.91%131.89M-82.81%1.94M117.59%15.41M1,628.91%5.86M2,078.00%108.68M-441.05%-70.95M426.21%11.3M-1,583.85%-87.58M-90.39%339K-45.91%4.99M
Net other financing activities -861.87%-6.89M--0--0--0---6.89M90.78%-716K61.31%-554K------------
Cash from discontinued financing activities
Financing cash flow -46.24%125M-81.92%1.94M-92.88%15.41M1,628.91%5.86M1,939.98%101.8M-58.60%232.51M-98.04%10.75M3,567.05%216.43M-90.39%339K72.49%4.99M
Net cash flow
Beginning cash position -53.62%985.8M-46.95%561.08M-1.82%870.95M-28.37%890.69M-53.62%985.8M40.60%2.13B-34.23%1.06B-48.01%887.06M-16.59%1.24B40.60%2.13B
Current changes in cash 52.46%-541.79M-62.95%-117.07M-281.65%-309.87M94.46%-19.74M89.22%-95.11M-285.68%-1.14B-113.89%-71.85M273.78%170.58M-265.46%-356.47M-4,137.90%-881.99M
End cash Position -54.96%444.01M-54.96%444.01M-46.95%561.08M-1.82%870.95M-28.37%890.69M-53.62%985.8M-53.62%985.8M-34.23%1.06B-48.01%887.06M-16.59%1.24B
Free cash flow -64.53%-588.34M26.71%-73.7M-109.11%-155.62M-84.66%-140.14M-105.09%-218.88M26.11%-357.6M-197.15%-100.56M44.28%-74.42M34.03%-75.89M47.04%-106.73M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg